Three London stocks are on the march and are expected to rise by more than 50% over the next 12 months. TM17-GB 1Y line More recently, RBC said the company reported "a good set of results" in September. The company reported £80.6 million in total sales, missing revenue expectations of £81.5 million marginally. Wheeler also noted that the stock had "significant upside potential" after the company reported its first-half results on July 26. RBC analyst Charles Weston said the stock remains "materially undervalued" after the company reported its first half-year financial results.

---

Persons: Debbie Bestwick's, Steve Bell's, Frank Sagnier's, Ross Broadfoot, Broadfoot, Team17, RBC's Alexander Wheeler, Wheeler, Charles Weston, OXB Organizations: CNBC Pro, RBC Capital Markets, RBC, Drax, Oxford Biomedica, Oxford, University of Oxford Locations: London, England, Team17